Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Inventory Average (2021 - 2025)

Historic Inventory Average for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Q3 2025 value amounting to $46.0 million.

  • Maravai Lifesciences Holdings' Inventory Average fell 789.37% to $46.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.0 million, marking a year-over-year decrease of 789.37%. This contributed to the annual value of $50.7 million for FY2024, which is 732.95% up from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Inventory Average stood at $46.0 million, which was down 789.37% from $48.2 million recorded in Q2 2025.
  • Maravai Lifesciences Holdings' Inventory Average's 5-year high stood at $61.3 million during Q3 2022, with a 5-year trough of $40.2 million in Q1 2021.
  • Moreover, its 5-year median value for Inventory Average was $50.3 million (2023), whereas its average is $50.4 million.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Inventory Average skyrocketed by 2801.94% in 2022 and then crashed by 2121.24% in 2023.
  • Maravai Lifesciences Holdings' Inventory Average (Quarter) stood at $53.9 million in 2021, then dropped by 2.07% to $52.8 million in 2022, then dropped by 4.77% to $50.3 million in 2023, then increased by 0.08% to $50.3 million in 2024, then dropped by 8.57% to $46.0 million in 2025.
  • Its Inventory Average stands at $46.0 million for Q3 2025, versus $48.2 million for Q2 2025 and $49.9 million for Q1 2025.